fbpx

Migraine Protein Therapy

- Welcome, SoundTherapy.com lowers anxiety 86%, pain 77%, and boosts memory 11-29%. Click on the brain to sign up or share with buttons below to help others:

Migraine Protein Therapy

Migraine can be a debilitating condition that causes severe, throbbing headaches, nausea, vomiting and extreme sensitivity to light and sound. Many people also experience visual disturbances called an aura.

Migraine is caused by changes in the brain, and new treatments are being developed to help reduce its attacks and symptoms. These medications target calcitonin gene-related peptide (CGRP), or CGRP for short.

CGRP, which is found in some individuals more than others, may contribute to inflammation in migraine sufferers’ brains. Anti-CGRP drugs block this signal, relieving pain and other symptoms associated with migraine.

Monoclonal antibodies (MAbs) and small molecule CGRP antagonists are the two types of CGRP inhibitors available: MAbs, which must be injected under the skin monthly; while smaller molecule CGRP antagonists can be taken orally in pill form.

CGRP inhibitors work by blocking the CGRP receptor in the brain, helping prevent its release into the bloodstream during a migraine attack. This lessens pain and other symptoms associated with migraine, and may prevent future attacks as well.

These drugs can be administered via injection, either under the skin or intravenously (IV). They have been developed to treat acute migraine and prevent future attacks. They typically need to be given once or twice a month depending on which treatment type you receive.

These medications are costly and need a doctor’s prescription; therefore, you should visit a neurologist or headache specialist before being eligible to obtain them. Your physician may want to do a blood test in order to rule out any medical conditions which might prevent you from taking the medication safely.

Be aware that these drugs can have serious side effects if taken by women with children or pregnant. Therefore, these medications are not advised for this group of individuals.

NHS patients can access anti-CGRP drugs through specialist headache clinics or consultant neurologist referral. However, there are various restrictions and waiting lists.

For UK patients, you will need to reach out to your GP or the National Health Service (NHS) for information regarding access to anti-CGRP drugs. As regulations on NHS access vary from country to country, it’s essential that you check with your local authority if these medications are available in your region.

Studies have demonstrated that anti-CGRP drugs may reduce migraine attacks in some individuals with chronic migraine, though more research is necessary to identify who would benefit most from this therapy.

These drugs can be purchased from several drug companies. Some are available in the United States, while others have been approved in other countries.

These new CGRP-targeted drugs are the first specifically designed to prevent migraines and have a significantly lower rate of adverse reactions than existing migraine therapeutics, suggesting they may be safe for more people.

Sign up here to try or learn about sound therapy that lowers anxiety, insomnia, pain, insomnia, and tinnitus an average of 77%.


- Welcome, SoundTherapy.com lowers anxiety 86%, pain 77%, and boosts memory 11-29%. Click on the brain to sign up or share with buttons below to help others:
SoundTherapy.com